Fecal calprotectin (FCP) is commonly used to help differentiate between irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD). It is a sensitive and stable biomarker that is not affected by medication or dietary supplements.
Quantitative fecal calprotectin results provide clear answers for new diagnoses and deliver valuable tracking information for ongoing treatment and disease monitoring.
Additionally, fecal calprotectin is an excellent predictor of relapse in patients with IBD. Clinicians rely on FCP levels to adjust treatment plans and reduce the severity of potential relapses.
FCP adds significant clinical value and, in some cases, can eliminate the need for invasive procedures such as endoscopy. With ProciseDx, this test can be completed in under 5 minutes during a patient visit.
| Parameter | Details |
|---|---|
| Sample Types | Stool from Procise Stool Collection Device |
| Reportable Range | 3.6 mg/L – 100 mg/L |
| Time to Results | 5 minutes |
| Assay Stability | 1 year at room temperature |
| Sample Stability | 5 days after sample collection |
Calibrated against WHO standard.